{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:13:22Z","timestamp":1791929602250,"version":"4.3.4"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Human parvovirus B19 (B19V) is one of the blood-borne viruses. The virus can be transmitted to susceptible individuals by blood or blood products. The virus is not associated with significant disease in general population, while people with underlying problems such as immunodeficiency can cause anemia and arthritis. The current systematic review and meta-analysis aimed to estimate the overall prevalence of B19V DNA, anti-B19V IgG, and anti-B19V IgM antibodies in blood donors worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A systematic search was carried out in online databases for relevant studies from inception until March 30, 2019. Study selection was performed based on predesigned eligibility criteria. The proportion of B19V DNA, anti-B19V IgG, and anti-B19V IgM antibodies were pooled using the inverse variance method. All statistical analyses were performed using the R version 3.5.3, package \u201cmeta.\u201d<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>According to the random-effects model, the pool prevalence of B19V DNA, anti-B19V IgM, and anti-B19V IgG among blood donors was calculated to be 0.4% (95% confidence interval [CI] =0.3%\u20130.6%), 2.2% (95% CI = 1.3%\u20133.7%), and 50.1% (95% CI = 43.1%\u201357.1%), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>For the transmission of B19V through blood, the presence of the virus genome is required, and the present study showed that the prevalence of the virus genome in blood donors is &lt;1%. Therefore, there is no need to screen donated blood for B19V infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ajts.ajts_185_20","type":"journal-article","created":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T10:40:33Z","timestamp":1636281633000},"page":"212-222","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Molecular and serological markers of human parvovirus B19 infection in blood donors"],"prefix":"10.4103","volume":"15","author":[{"given":"Mohammad","family":"Farahmand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saied","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hamidreza","family":"Monavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Jalal","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Minaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20240830","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000119114","article-title":"Supply with platelet concentrates from the point of view of a blood donation service of the Bavarian Red Cross","volume":"35","author":"Weinauer","year":"2008","journal-title":"Transfus Med Hemother"},{"key":"R2-17-20240830","doi-asserted-by":"crossref","first-page":"38","DOI":"10.14196\/mjiri.32.38","article-title":"Frequency of human parvovirus B19 among patients with respiratory infection in Iran","volume":"32","author":"Tavakoli","year":"2018","journal-title":"Med J Islam Repub Iran"},{"key":"R3-17-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317703634","article-title":"Detection and a possible link between parvovirus B19 and thyroid cancer","volume":"39","author":"Etemadi","year":"2017","journal-title":"Tumour Biol"},{"key":"R4-17-20240830","first-page":"113","article-title":"Molecular prevalence of parvovirus B19 among HIV1-infected patients in Iran","volume":"32","author":"Kiani","year":"2018","journal-title":"Med J Islam Repub Iran"},{"key":"R5-17-20240830","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijid.2017.09.018","article-title":"Detection of human parvovirus B19 in serum samples from children under 5 years of age with rash-fever illnesses in the Democratic Republic of the Congo","volume":"65","author":"Wawina","year":"2017","journal-title":"Int J Infect Dis"},{"key":"R6-17-20240830","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/jmv.25195","article-title":"Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors","volume":"90","author":"Zadsar","year":"2018","journal-title":"J Med Virol"},{"key":"R7-17-20240830","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5045\/br.2017.52.1.50","article-title":"Human parvovirus B19 in patients with beta thalassemia major from Tehran, Iran","volume":"52","author":"Arabzadeh","year":"2017","journal-title":"Blood Res"},{"key":"R8-17-20240830","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5045\/br.2017.52.4.311","article-title":"Human parvovirus B19 and parvovirus 4 among Iranian patients with hemophilia","volume":"52","author":"Javanmard","year":"2017","journal-title":"Blood Res"},{"key":"R9-17-20240830","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R10-17-20240830","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1002\/hpm.2184","article-title":"Prevalence of unwanted pregnancy in Iran: A systematic review and meta-analysis","volume":"29","author":"Moosazadeh","year":"2014","journal-title":"Int J Health Plann Manage"},{"key":"R11-17-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-3327.223616","article-title":"Prevalence of orthodontic treatment need in permanent dentition of Iranian population: A systematic review and meta-analysis of observational studies","volume":"15","author":"Eslamipour","year":"2018","journal-title":"Dent Res J (Isfahan"},{"key":"R12-17-20240830","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R13-17-20240830","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: Comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R15-17-20240830","first-page":"40","article-title":"Meta: An R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R News"},{"key":"R16-17-20240830","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.31.2.323-328.1993","article-title":"Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction","volume":"31","author":"McOmish","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R17-17-20240830","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","article-title":"Incidence of human parvovirus B19 DNA detection in blood donors","volume":"91","author":"Yoto","year":"1995","journal-title":"Br J Haematol"},{"key":"R18-17-20240830","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0955-3886(97)00049-0","article-title":"Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: Differential implications for prevention of transfusional transmission","volume":"18","author":"Leta\u00efef","year":"1997","journal-title":"Transfus Sci"},{"key":"R19-17-20240830","first-page":"25","article-title":"Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia","volume":"16","author":"Mata Reb\u00f3n","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R20-17-20240830","first-page":"161","article-title":"Seroprevalence versus parvovirus B19 in blood donors","volume":"16","author":"Mu\u00f1oz","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R21-17-20240830","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1423-0410.2003.00299.x","article-title":"Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins","volume":"84","author":"Thomas","year":"2003","journal-title":"Vox Sang"},{"key":"R22-17-20240830","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.78.22.12169-12178.2004","article-title":"Identification and characterization of persistent human erythrovirus infection in blood donor samples","volume":"78","author":"Candotti","year":"2004","journal-title":"J Virol"},{"key":"R23-17-20240830","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1017\/S0950268804002389","article-title":"Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors","volume":"132","author":"Manaresi","year":"2004","journal-title":"Epidemiol Infect"},{"key":"R24-17-20240830","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.transci.2005.06.002","article-title":"Prevalence of parvovirus B19 and hepatitis A virus in Portuguese blood donors","volume":"33","author":"Henriques","year":"2005","journal-title":"Transfus Apher Sci"},{"key":"R25-17-20240830","first-page":"60","article-title":"Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province","volume":"20","author":"Wei","year":"2006","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"R26-17-20240830","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1111\/j.1537-2995.2007.01341.x","article-title":"Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay","volume":"47","author":"Kleinman","year":"2007","journal-title":"Transfusion"},{"key":"R27-17-20240830","first-page":"443","article-title":"Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, Chile","volume":"135","author":"Gaggero","year":"2007","journal-title":"Rev Med Chil"},{"key":"R28-17-20240830","first-page":"47","article-title":"Prevalence of parvovirus B19 in blood donors tested by ELISA and PCR","volume":"5","author":"Mahmudi","year":"2008","journal-title":"Sci J Iran Blood Transfus Organ"},{"key":"R29-17-20240830","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2230-8229.96529","article-title":"Seroprevalence of erythrovirus B19 IgG among Saudi blood donors in Makkah, Saudi Arabia","volume":"16","author":"Johargy","year":"2009","journal-title":"J Family Community Med"},{"key":"R30-17-20240830","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1177\/0961203310375438","article-title":"Parvovirus B19 and C-reactive protein in blood bank donors: Implications for hygiene hypothesis research","volume":"19","author":"O'Bryan","year":"2010","journal-title":"Lupus"},{"key":"R31-17-20240830","first-page":"58","article-title":"Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors","volume":"30","author":"Oh","year":"2010","journal-title":"Korean J Lab Med"},{"key":"R32-17-20240830","first-page":"67","article-title":"Detection of parvovirus B19 markers in blood samples of donors","volume":"5","author":"Filatova","year":"2010","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"R33-17-20240830","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1111\/j.1537-2995.2011.03067.x","article-title":"The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers","volume":"51","author":"Ke","year":"2011","journal-title":"Transfusion"},{"key":"R34-17-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21859\/isv.5.2.9","article-title":"Detection of human parvovirus B19 markers in blood samples of donors","volume":"5","author":"Mahmoodian-Shooshtari","year":"2011","journal-title":"Iran J Virol"},{"key":"R35-17-20240830","first-page":"7","article-title":"Parvovirus B19 DNA testing in Polish blood donors, 2004-2010","volume":"66","author":"Grabarczyk","year":"2012","journal-title":"Przegl Epidemiol"},{"key":"R36-17-20240830","first-page":"502","article-title":"Human immunodeficiency virus\/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China","volume":"10","author":"He","year":"2012","journal-title":"Blood Transfus"},{"key":"R37-17-20240830","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1139\/w11-119","article-title":"Genotyping of human parvovirus B19 among Brazilian patients with hemoglobinopathies","volume":"58","author":"Slavov","year":"2012","journal-title":"Can J Microbiol"},{"key":"R38-17-20240830","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jmv.23358","article-title":"Molecular and phylogenetic analyses of human parvovirus B19 isolated from Brazilian patients with sickle cell disease and \u03b2-thalassemia major and healthy blood donors","volume":"84","author":"Slavov","year":"2012","journal-title":"J Med Virol"},{"key":"R39-17-20240830","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.mjafi.2012.11.009","article-title":"Seroprevalence of human parvovirus B19 in healthy blood donors","volume":"69","author":"Kumar","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"R40-17-20240830","first-page":"14","article-title":"Seroprevalence of parvovirus BI9 antibody in blood donors and sickle cell disease patients at Lagos University Teaching Hospital (LUTH): A comparative study","volume":"15","author":"Iheanacho","year":"2014","journal-title":"Afr J Clin Exp Microbiol"},{"key":"R41-17-20240830","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000357650","article-title":"Parvovirus b19 infections and blood counts in blood donors","volume":"41","author":"Juhl","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"R42-17-20240830","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/tme.12259","article-title":"The prevalence of hepatitis A virus and parvovirus B19 in source-plasma donors and whole blood donors in China","volume":"25","author":"Han","year":"2015","journal-title":"Transfusion Med"},{"key":"R43-17-20240830","first-page":"1572","article-title":"Prevalence of parvovirus B19 infection in Chinese Xiamen Area blood donors","volume":"24","author":"Ou","year":"2016","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"R44-17-20240830","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12288-015-0607-1","article-title":"Prevalence and viral load of human parvovirus B19 (B19V) among blood donors in South-East Brazil","volume":"32","author":"Slavov","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R45-17-20240830","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jmv.24459","article-title":"Epidemiologic study of human parvovirus B19 infection in East China","volume":"88","author":"Zhang","year":"2016","journal-title":"J Med Virol"},{"key":"R46-17-20240830","first-page":"12","article-title":"Bush molecular detection of human parvovirus B19 among blood donors in Southern Darfur State, Sudan","volume":"2","author":"Osman","year":"2017","journal-title":"Afr J Med Sci"},{"key":"R47-17-20240830","first-page":"1","article-title":"Seroprevalance of human parvovirus B19 among blood donor volunteers from Sudanese Blood Bank in Khartoum State 2017","volume":"2","author":"Omer","year":"2017","journal-title":"J Immuno Biol"},{"key":"R48-17-20240830","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4314\/ahs.v18i3.5","article-title":"Seroprevalence of parvovirus B19 in blood donors: The risks and challenges of blood transfusion in Zambia in the era of HIV\/AIDS at the Kitwe Central Hospital, blood bank","volume":"18","author":"Chirambo-Kalolekesha","year":"2018","journal-title":"Afr Health Sci"},{"key":"R49-17-20240830","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12879-018-3525-7","article-title":"Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia","volume":"18","author":"Faddy","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R50-17-20240830","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3906\/sag-1802-150","article-title":"Parvovirus B19 seroprevalence in Turkish blood donors","volume":"48","author":"G\u00f6ral","year":"2018","journal-title":"Turk J Med Sci"},{"key":"R51-17-20240830","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.transci.2018.07.017","article-title":"Seroprevalence of human parvovirus B19 amongst North Indian blood donors-Do current donor testing guidelines need a relook?","volume":"57","author":"Raturi","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"R52-17-20240830","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5935\/1676-2444.20180041","article-title":"Serological and molecular evaluation of parvovirus B19 (B19V) in blood donors from the Blood Center of Bras\u00edlia, Brazil: Focus on women of childbearing age","volume":"54","author":"Silva","year":"2018","journal-title":"J Bras Patol Med Lab"},{"key":"R53-17-20240830","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/jmv.25450","article-title":"Parvovirus B19 in South African blood donors","volume":"91","author":"Francois","year":"2019","journal-title":"J Med Virol"},{"key":"R54-17-20240830","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1099\/jmm.0.000957","article-title":"Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil","volume":"68","author":"Slavov","year":"2019","journal-title":"J Med Microbiol"},{"key":"R55-17-20240830","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jmv.25453","article-title":"Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil","volume":"91","author":"Slavov","year":"2019","journal-title":"J Med Virol"},{"key":"R56-17-20240830","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cmi.2014.09.009","article-title":"Increased number of parvovirus B19 infections in southeast Scotland in 2012-2013","volume":"21","author":"Al Shukri","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R57-17-20240830","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/j.1537-2995.2007.01443.x","article-title":"Blood donor screening for parvovirus B19 in Germany and Austria","volume":"47","author":"Schmidt","year":"2007","journal-title":"Transfusion"},{"key":"R58-17-20240830","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1423-0410.2010.01423.x","article-title":"Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003\u20132009","volume":"100","author":"Kooistra","year":"2011","journal-title":"Vox Sang"}],"container-title":["Asian Journal of Transfusion Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_185_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:12:20Z","timestamp":1787166740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ajts.ajts_185_20"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ajts.ajts_185_20","relation":{},"ISSN":["0973-6247"],"issn-type":[{"value":"0973-6247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}